AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.Ā
Santosā plan to reach net zero greenhouse gas emissions by 2040 was ālittle more than a series of speculationsā, a shareholder group has said on the first day of trial in a landmark greenwashing case.
S&P is free to pay for a Rolls-Royce defence in “Rolls-Royce litigation” that alleges the agency engaged in fraud in assigning ratings to risky financial products, a judge has said.
Homes Victoria says the decision to demolish public housing towers in Melbourne — now the subject of a class action — took residents’ human rights into account, but has no documents to show it.
Former radio host Antoinette Lattouf will argue at trial that the ex-chair of the ABC, Ita Buttrose, and managing director David Anderson were involved in the decision to terminate her contract.Ā
Dairy company Care A2 has settled a dispute with Gensco Laboratories over an agreement to distribute its infant formula in the US that went sour.
The funder bankrolling a class action by residents allegedly displaced by the construction of the $16.8 billion WestConnex tunnel has abandoned the case.
A class action targeting Westpac subsidiary BT Funds and Tal Life Insurance was discontinued after documents discovered by the companies caused funder Woodsford to bow out.
A ‘junk’ insurance class action against Suncorp unit AAI wants an initial trial to deal with the claim — absent a sample group member — that car dealers made purchasing a policy necessary for a loan.
Years of hard fought litigation by axed Qantas ground crew and generic drug maker Sandoz ended in victory this week, thanks to legal eagles from Maurice Blackburn and Ashurst and their counsel. The week opened with a bang with a decision from Federal Court Justice Michael Lee in three landmark test cases by the Transport…